RxCap
RxCap is a company dedicated to improving medication adherence and supporting healthcare enterprises with modular software, APIs, devices, and services. Their mission is to enable better patient outcomes through innovative remote monitoring and adherence solutions, integrating with healthcare workflows and providing real-time data for proactive care.
Industries
Nr. of Employees
small (1-50)
Products
Connected medication adherence devices
Sensor-enabled medication containers and weekly pill organizers with embedded cellular connectivity that detect dosing events and transmit data to a cloud platform.
Data hub and aggregator devices
Hardware gateways and proprietary data hubs that collect device data and manage secure transmission to cloud services for patient monitoring programs.
Patient activation mobile and web applications
Patient-facing applications for medication reminders, manual adherence confirmation, medication education import and caregiver notifications.
Provider portal and analytics dashboard
Cloud-based portal for clinicians and pharmacy staff to view adherence events, run reports, and perform outreach interventions.
Connected medication adherence devices
Sensor-enabled medication containers and weekly pill organizers with embedded cellular connectivity that detect dosing events and transmit data to a cloud platform.
Data hub and aggregator devices
Hardware gateways and proprietary data hubs that collect device data and manage secure transmission to cloud services for patient monitoring programs.
Patient activation mobile and web applications
Patient-facing applications for medication reminders, manual adherence confirmation, medication education import and caregiver notifications.
Provider portal and analytics dashboard
Cloud-based portal for clinicians and pharmacy staff to view adherence events, run reports, and perform outreach interventions.
Services
Modular cloud platform and operational service to onboard, manage and monitor connected adherence devices and third-party physiological integrations for enterprise customers.
APIs and integration services to connect device data to EHRs, provider portals, and partner platforms enabling event-level adherence data exchange.
End-to-end program deployment for pharmacies that includes connected devices, cloud software, operational support and training to launch reimbursable remote monitoring services.
Provisioning of adherence devices and integration with study workflows to capture high-resolution adherence data for clinical trials and observational studies.
Modular cloud platform and operational service to onboard, manage and monitor connected adherence devices and third-party physiological integrations for enterprise customers.
APIs and integration services to connect device data to EHRs, provider portals, and partner platforms enabling event-level adherence data exchange.
End-to-end program deployment for pharmacies that includes connected devices, cloud software, operational support and training to launch reimbursable remote monitoring services.
Provisioning of adherence devices and integration with study workflows to capture high-resolution adherence data for clinical trials and observational studies.
Expertise Areas
- Medication adherence monitoring
- Remote therapeutic monitoring (RTM) and remote patient monitoring (RPM)
- EHR/EMR integration and App Orchard/EHR marketplace deployment
- Device-cloud integration and IoT connectivity
Key Technologies
- LTE / cellular device connectivity
- Cloud-based analytics and data platform
- APIs and integration libraries
- Mobile and web patient applications
News & Updates
RxCap's proprietary medication adherence technology was implemented in a clinical study focusing on stroke survivors’ adherence to their medication regime, showing a 90.9% adherence rate.
RxCap announced a partnership with ZEPHYRx to integrate cloud spirometry into its remote monitoring platform, enabling enterprise customers to monitor lung function of patients with pulmonary conditions.
Gerresheimer acquired a minority stake in RxCap and received exclusive distribution rights for adherence solutions in U.S. pharmacies, including connected prescription vial closure devices and cloud software.
Wysa partnered with RxCap to integrate remote monitoring technology into Wysa’s care platform, supporting providers in tracking real-time medication adherence data.
This article discusses the limitations of the traditional Proportion of Days Covered (PDC) metric and advocates for real-time monitoring technologies to improve clinical utility and patient outcomes.
This article explains the evolution of remote therapeutic monitoring (RTM), its clinical benefits, and how it supports proactive, personalized patient care.
RxCap's proprietary medication adherence technology was implemented in a clinical study focusing on stroke survivors’ adherence to their medication regime, showing a 90.9% adherence rate.
RxCap announced a partnership with ZEPHYRx to integrate cloud spirometry into its remote monitoring platform, enabling enterprise customers to monitor lung function of patients with pulmonary conditions.
Gerresheimer acquired a minority stake in RxCap and received exclusive distribution rights for adherence solutions in U.S. pharmacies, including connected prescription vial closure devices and cloud software.
Wysa partnered with RxCap to integrate remote monitoring technology into Wysa’s care platform, supporting providers in tracking real-time medication adherence data.
This article discusses the limitations of the traditional Proportion of Days Covered (PDC) metric and advocates for real-time monitoring technologies to improve clinical utility and patient outcomes.
This article explains the evolution of remote therapeutic monitoring (RTM), its clinical benefits, and how it supports proactive, personalized patient care.